Join to view full profile
601 Crittenden BlvdRochester, NY 14642
Phone+1 585-275-5823
Dr. Mulkerin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Mulkerin, based in Rochester, NY, is an oncology specialist with a clinical focus in gastrointestinal cancer. He completed his medical degree at Sidney Kimmel Medical College in 1992, followed by a residency in Internal Medicine and a fellowship in Medical Oncology at the University of Wisconsin Hospitals and Clinics. Dr. Mulkerin served as medical director at UW Carbone Cancer Center from 2006 to 2021. He has contributed to publications in notable journals and has been involved in clinical trials focusing on colorectal and anal cancer treatments. Dr. Mulkerin has served at the University of Rochester Wilmot Cancer Institute since 2001, growing regional presence, continuing clinical and research efforts on gi cancers, and serving as Medical Director since 2023.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1996 - 1999- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1992 - 1996
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1992
Certifications & Licensure
NY State Medical License 2021 - 2028
WI State Medical License 1993 - 2027
IL State Medical License 2014 - 2017
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Total Neoadjuvant Therapy with FOLFOX Followed by Short-Course Radiation in Locally Advanced Rectal Cancer-An Alternative Approach Evaluated in a Single-Center Clinica...Janice Zhao, Andrea M Baran, Larissa K F Temple, Wenjia Wang, Jason Zittel
Journal of Clinical Medicine. 2026-04-22 - 3 citationsGABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancer.Carly Strelez, Francesca Battaglin, Rachel Perez, Yan Yang, Christopher Cherry
Oncogene. 2025-10-01 - 8 citationsSubclonal response heterogeneity to define cancer organoid therapeutic sensitivity.Jeremy D Kratz, Shujah Rehman, Katherine A Johnson, Amani A Gillette, Aishwarya Sunil
Scientific Reports. 2025-04-09
Press Mentions
Wilmot Cancer Institute Welcomes Leading Rochester Breast Cancer Surgeon Lori Medeiros, MDFebruary 28th, 2025- Wilmot Cancer Institute Brings Multidisciplinary Cancer Care to WebsterJuly 7th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
